Age- and sex-associated changes in cardiac β1-adrenoceptors from the muscular dystrophy (mdx) mouse

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 9, 2000, Pages 1661-1668

  Lu, Sai ^a   Hoey, Andrew ^a  

^a UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Aging; Cardiac rate and force of contraction.; Duchenne muscular dystrophy (DMD); Mdx mice; 1 adrenoceptors

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR; ISOPRENALINE;

AGING; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; HEART CONTRACTION; HEART RATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033804275     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1200     Document Type: Article

References (34)

1. Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests
2. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy
3. Molecular basis of hypertrophic and dilated cardiomyopathy
4. Dystrophic cardiomyopathy in Duchenne definite carriers (electrocardiographic and echocardiographic findings)
5. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy
6. Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy
7. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becket muscular dystrophy
8. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts
9. 2-Adrenoceptors in the human heart: Properties, function and alterations in chronic heart failure
10. Physiology and pharmacology of cardiovascular catecholamine receptors: Implications for treatment of chronic heart failure
11. Function of cardiac adrenergic and muscarinic receptors in the dystrophin deficient mdx mouse
12. Development of cardiomyopathy in female carriers of Duchenne and Becket muscular dystrophies
13. Some quantitative uses of drug antagonists
14. 2 and affinity constants for pharmacological competitive antagonists be estimated?
15. Echocardiography in Duchenne dystrophy
16. mdx Mice show progressive weakness and muscle deterioration with age
17. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice
18. The classification of drugs and drug receptors in isolated tissue
19. A carrier of Duchenne muscular dystrophy with dilated cardiomyopathy but no skeletal muscle symptom
20. Prevalent cardiac involvement in dystrophin Beaker type mutation
21. Cardiomyopathy in female carriers of the Duchenne gene
22. A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms
23. Dystrophin negative skeletal and myocardial muscle cells in a carrier of Duchenne's muscular dystrophy
24. Myocardial involvement in carrier states for Duchenne muscular dystrophy. A rare cause of supraventricular arrhythmia
25. Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters
26. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus
27. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: Role of the L-type calcium channel
28. Positive inotropic stimulation in the normal and insufficient human myocardium
29. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: No difference in dilated versus ischemic cardiomyopathy
30. Assay of adenylate cyclase in homogenates of control and Duchenne human skeletal muscle
31. Adenyl cyclase abnormality in Duchenne muscular dystrophy: Muscle cells in culture
32. Adenyl cyclase activity in Duchenne dystrophic muscle
33. Phenotype of dystrophinopathy in old mdx mice
34. Calcium homeostasis in dys-trophic muscle